{
  "report_rows": [
    {
      "kpi": "Adj. EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2.17 vs. cons ~$2.10",
      "confidence": "HIGH"
    },
    {
      "kpi": "Organic Revenue Growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~+4.7% vs. cons +3.69%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "HST Segment Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$420M vs. cons $406M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adj. EPS (Q3 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.20 vs. cons $2.19",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EPS (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~$8.65 midpoint vs. cons ~$8.45",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic Growth (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~4.5% midpoint vs. cons +3.99%",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 5.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 5.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 FY guide raise pulls H2 estimates up; sell-side revisions drive follow-through over 3-5 days",
  "day5_confidence": "MEDIUM"
}